IN VITRO STUDY OF A TRANSFERSOMAL GEL PREPARATION CONTAINING LYNESTRENOL AS A TRANSDERMAL DRUG DELIVERY SYSTEM

Authors

  • NURFITRIYANA NURFITRIYANA Department of Pharmacy, Physical Pharmacy Laboratory, Faculty of Pharmacy, Universitas, Indonesia
  • HARMITA HARMITA Department of Pharmacy, Physical Pharmacy Laboratory, Faculty of Pharmacy, Universitas, Indonesia
  • ISKANDARSYAH ISKANDARSYAH Department of Pharmacy, Physical Pharmacy Laboratory, Faculty of Pharmacy, Universitas, Indonesia

DOI:

https://doi.org/10.22159/ijap.2020.v12s1.FF052

Keywords:

Transfersomes, Lynestrenol, Franz diffusion cell

Abstract

Objective: Lynestrenol, a progestin hormone derivative, can suppress the productions of endogenous estrogen and progesterone hormones (ovaries)
to prevent ovulation. In this study, lynestrenol was included in various transfersomal gel preparations for its transdermal delivery into fat (F)-and
non-fat (NF)-containing skin tissues.
Methods: Lynestrenol transfersome vesicles were prepared by encapsulating the drug in varied concentrations of phosphatidylcholine and Tween
80 using lipid film hydration method. Transfersomes were produced in the form of gel preparations at a dose of 0.15 mg/week and evaluated for
their particle size, percentage of entrapment efficiency, and particle polydispersity. We performed in vitro evaluations of the formulation variants F0
(lynestrenol gel control) and F1 and F2 (lynestrenol transfersome gels) with variations in their phosphatidylcholine and Tween 80 content. We then
performed an in vitro evaluation using the Franz diffusion cell (FDC) method for 12 h using all three formulations on F and NF-containing rat skin.
Results: The FDC results demonstrated that lynestrenol was deposited into fat tissue and increased concentrations of Tween 80 (edge activator)
increased lynestrenol delivery into this tissue. In addition, the percentages of drug penetration from NF rat skin treated with F0, F1, and F2 gels were
19.56%, 20.13%, and 20.56%, respectively, and those from F rat skin were 17.16%, 17.38%, and 17.50%, respectively.
Conclusion: In vitro evaluation using the FDC method indicates that transdermal drug delivery through to fat tissues using transfersomes is a
promising method for lynestrenol delivery.

Downloads

Download data is not yet available.

References

1. Graziottin A. A review of transdermal hormonal contraception: Focus
on the ethinylestradiol/norelgestromin contraceptive patch. Treat
Endocrinol 2006;5:359-65.
2. Burkman RT. The transdermal contraceptive system. Am J Obstet
Gynecol 2004;190:S49-53.
3. Smallwood GH, Meador ML, Lenihan JP, Shangold GA, Fisher AC,
Creasy GW, et al. Efficacy and safety of a transdermal contraceptive
system. Obstet Gynecol 2001;98:799-805.
4. Audet MC, Moreau M, Koltun WD. Evaluation of contraception
efficacy and cycle control of transdermal contraceptive patch vs oral
contraception. Int J Ginecolobstet 2001;70:78.
5. Archer DF, Bigrigg A, Smallwood GH, Shangold GA, Creasy GW,
Fisher AC. Assessment of compliance with a weekly contraceptive
patch (Ortho Evra/Evra) among North American women. Fertil Steril
2002;77:S27-31.
6. Reddy D. Transfersomea novel vascular carrier for transdermal drug
delivery system. J Innov Pharm Biol Sci 2015;2:193-208.
7. Prajapati ST, Charmi GP, Chhagan N. Transfersomes: A vesicular
carrier system for transdermal drug delivery. Asian J Biochem Pharm
Res 2011;1:507-24.
8. Bazlad A, Wiweko B, Hendarto H. Tips for Managing Menstrual
Patterns during Hajj and Umrah: Basic Mechanisms, Problems and
Solutions [Kiatmengaturpolahaidsaat Haji Danumrah: Mekanismedasar,
Masalahdansolusinya]. Jakarta: Himpunan Endokrinologi Reproduksidan
Fertilitas; 2007.
9. Saman RR. Flight Health in the Hajj [Kesehatanpenerbangandalamibadah
Haji]. Indonesia, Jakarta: Badan Penerbit Fakultas Kedokteran
Universitas; 2011.
10. Yasuda J, Honjo H, Okada H. Metabolism of lynestrenol:
Characterization of 3-hydroxylation using rabbit liver microsomes
in vitro. J Steroid Biochem 1984;21:777-80.
11. Iskandarsyah I, Alvina WP, Ernysagita E. Penetration test of caffein
in ethosome and desmosome gel using an in vitro method. Int J Appl
Pharm 2017;9:1.
12. Rajan R, Vasudevan DT. Effect of permeation enhancers on the
penetration mechanism of transfersomal gel of ketoconazole. J Adv
Pharm Technol Res 2012;3:112-6.
13. Anggraini W, Erny S, Iskandarsyah I. Effect of hifrophilicity surfactant
toward characterization and in vitro transfersomes penetration in gel
using Franz diffusion test. Int J Appl Pharm 2017;9:1.
14. Reza MI, Divya G, Rahul KG, Musarrat HW. Formulation of
ketoconazole loaded nano dispersive gel using swollen micelles
technique and its in vitro characterization. Int J Pharm Pharm Sci
2018;10:162-6.
15. Nurleli N, Iskandarsyah I, Ahmad A. Formulation and penetration
testing of ethosome azelaic acid on abdomen skin white rats

Published

23-03-2020

How to Cite

NURFITRIYANA, N., HARMITA, H., & ISKANDARSYAH, I. (2020). IN VITRO STUDY OF A TRANSFERSOMAL GEL PREPARATION CONTAINING LYNESTRENOL AS A TRANSDERMAL DRUG DELIVERY SYSTEM. International Journal of Applied Pharmaceutics, 12(1), 242–244. https://doi.org/10.22159/ijap.2020.v12s1.FF052

Issue

Section

Original Article(s)